Hologic Announces Financial Results for Second Quarter Fiscal 2015

Go back to Hologic Announces Financial Results for Second Quarter Fiscal 2015

Hologic (HOLX) PT Boosted to $37 at Leerink Partners Amid 'Strong' Q2

April 30, 2015 6:33 AM EDT

Leerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on Hologic (NASDAQ: HOLX) to $37.00 (from $34.00) following "strong" Q2 results.

commented, "HOLX delivered a strong F2Q led by solid tomo sales (now ~1800 placements in US) and strength in... More

Hologic (HOLX) Tops Q2 EPS by 2c, Raises FY15 Guidance

April 29, 2015 5:04 PM EDT

Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $655.5 million versus the consensus estimate of $646.49 million.

Hologic sees FY2015 EPS of $1.57-$1.59, versus prior guidance of $1.54-$1.57 and the consensus of $1.57. Hologic... More